Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
CHINA HEALTH GROUP INC.
中 國 醫 療 集 團有 限 公 司
(Carrying on business in Hong Kong as "萬全醫療集團")
(Incorporated in the Cayman Islands with limited liability)
(Stock Code: 08225)
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED
31 DECEMBER 2021
CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED
(THE "STOCK EXCHANGE")
GEM has been positioned as a market designed to accommodate small and mid-sized companies to which a higher investment risk may be attached than other companies listed on the Stock Exchange. Prospective investors should be aware of the potential risks of investing in such companies and should make the decision to invest only after due and careful consideration.
Given that the companies listed on GEM are generally small and mid-sized companies, there is a risk that securities traded on GEM may be more susceptible to high market volatility than securities traded on the Main Board and no assurance is given that there will be a liquid market in the securities traded on GEM.
Hong Kong Exchanges and Clearing Limited and the Stock Exchange take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
This announcement for which the directors (the "Directors") of China Health Group Inc. (the "Company" and together with its subsidiaries, the "Group") collectively and individually accept full responsibility, includes particulars given in compliance with the Rules Governing the Listing of Securities on the GEM of the Stock Exchange (the "GEM Listing Rules") for the purpose of giving information with regard to China Health Group Inc. The Directors, having made all reasonable enquires, confirm that, to the best of their knowledge and belief: (1) the information contained in this announcement is accurate and complete in all material respects and not misleading or deceptive; (2) there are no other matters the omission of which would make any statement in this announcement herein or this announcement misleading; and (3) all opinions expressed in this announcement have been arrived at after due and careful consideration and are found on bases and assumptions that are fair and reasonable.
HIGHLIGHTS
1. The Group recorded a consolidated turnover of approximately RMB83,601,000 for the year ended 31 December 2021 (the "Year"), which represents approximately 0.65% increase from approximately RMB83,063,000 for the year ended 31 December 2020.
2. The Group recorded a profit before taxation of approximately RMB42,521,000 for the Year, which represents approximately 39.9% decrease from approximately RMB70,796,000 for the year ended 31 December 2020.
3. The Group recorded an operating cash outflow before tax paid of approximately RMB6,616,000 for the Year, as compared with operating cash inflow before tax paid of approximately RMB20,619,000 in year 2020.
4. The basic and diluted earnings per share are RMB3.65 cents in 2021, while basic and diluted earnings per share were RMB6.10 cents and RMB6.08 cents respectively in year 2020.
The board of Directors of the Company (the "Board") is pleased to announce the audited consolidated results of the Company and its subsidiaries (collectively the " Group " ) for the year ended 31 December 2021 together with the comparative audited figures for the year ended 31 December 2020 as follows:
CHINA HEALTH GROUP INC.
中國醫療集團有限公司
CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2021
Notes | 2021 | 2020 | |
RMB'000 | RMB'000 | ||
REVENUE | 5 | 83,601 | 83,063 |
Cost of services | (19,744) | (16,104) | |
Other income | 6 | 431 | 303 |
Administrative expenses | (14,433) | (3,600) | |
Staff costs | (7,337) | (8,288) | |
PROFIT FROM OPERATIONS | 42,518 | 55,374 | |
Finance costs | 7(a) | (15) | (163) |
Gain on disposal of subsidiaries | 28 | 18 | 15,585 |
PROFIT BEFORE TAXATION | 7 | 42,521 | 70,796 |
Income tax | 10 | (6,196) | (10,146) |
PROFIT AND TOTAL COMPREHENSIVE INCOME FOR THE | |||
YEAR | 36,325 | 60,650 | |
PROFIT AND TOTAL COMPREHENSIVE INCOME | |||
FOR THE YEAR ATTRIBUTABLE TO: | |||
Owners of the Company | 36,325 | 60,650 | |
36,325 | 60,650 | ||
EARNINGS PER SHARE (RMB cents) | 11 | ||
- Basic | 3.65 | 6.10 | |
- Diluted | 3.65 | 6.08 |
- 3-
CHINA HEALTH GROUP INC.
中國醫療集團有限公司
CONSOLIDATED STATEMENT OF FINANCIAL POSITION AS AT 31 DECEMBER 2021
Notes | 2021 | 2020 | |
RMB'000 | RMB'000 | ||
NON-CURRENT ASSETS | |||
Property, plant and equipment | 13 | 1,550 | 1,751 |
Right-of-use assets | 14 | - | - |
1,550 | 1,751 | ||
CURRENT ASSETS | |||
Investments at fair value through profit or loss | 16 | 5,660 | 12,160 |
Contract costs | 17 | 24,481 | 24,800 |
Trade and bills receivables | 18 | 128,513 | 86,056 |
Trade deposit paid | 19 | 1,800 | 1,800 |
Prepayments, deposits and other receivables | 20 | 24,742 | 17,135 |
Cash and cash equivalents | 11,364 | 16,193 | |
196,560 | 158,144 | ||
CURRENT LIABILITIES | |||
Trade payables, other payables and accrued charges | 21 | 19,009 | 18,594 |
Contract liabilities | 17 | 1,014 | 1,161 |
Lease liabilities | - | - | |
Tax payable | 22,515 | 19,965 | |
Bank borrowings | 22 | - | 1,500 |
42,538 | 41,220 | ||
NET CURRENT ASSETS | 154,022 | 116,924 | |
TOTAL ASSETS LESS CURRENT LIABILITIES | 155,572 | 118,675 | |
NON-CURRENT LIABILITIES | |||
Lease liabilities | - | - | |
- | - | ||
NET ASSETS | 155,572 | 118,675 | |
EQUITY | |||
Equity attributable to owners of the Company | |||
Issued capital | 23 | 88,906 | 88,906 |
Reserves | 23 | 66,666 | 29,769 |
Total equity | 155,572 | 118,675 | |
- 4- |
CHINA HEALTH GROUP INC.
中國醫療集團有限公司
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2021
Issued | Share | payment | Special | Capital | Statutory | |
capital | premium * | reserve * | reserve * | reserve * | reserve * | |
RMB'000 | RMB'000 | RMB'000 | RMB'000 | RMB'000 | RMB'000 | |
At 1 January 2020 | 88,673 | - | 2,894 | 6,039 | 6,231 | 12,738 |
Profit and total comprehensive income for the | ||||||
year | - | - | - | - | - | - |
Cancellation/Lapse of share options | - | - | (31) | - | - | - |
Shares issued upon exercise of share options | 233 | 1,402 | (590) | - | - | - |
Appropriations | - | - | - | - | - | 6,813 |
At 31 December 2020 | 88,906 | 1,402 | 2,273 | 6,039 | 6,231 | 19,551 |
At 1 January 2021 | 88,906 | 1,402 | 2,273 | 6,039 | 6,231 | 19,551 |
Profit and total comprehensive income for the | ||||||
year | - | - | - | - | - | - |
Share-based payment | - | - | 572 | - | - | - |
Appropriations | - | - | - | - | - | 4,110 |
At 31 December 2021 | 88,906 | 1,402 | 2,845 | 6,039 | 6,231 | 23,661 |
Attributable to owners of the Company | ||
Statutory | ||
Share-based | enterprise | |
expansion | Accumulated | Total |
fund * | (losses)/profits * | equity |
RMB'000 | RMB'000 | RMB'000 |
6,986 | (66,581) | 56,980 |
- | 60,650 | 60,650 |
- | 31 | - |
- | - | 1,045 |
- | (6,813) | - |
6,986 | (12,713) | 118,675 |
6,986 | (12,713) | 118,675 |
- | 36,325 | 36,325 |
- | - | 572 |
- | (4,110) | - |
6,986 | 19,502 | 155,572 |
*These reserve accounts comprise the consolidated reserves in the consolidated statement of financial position.
- 5 -
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
China Health Group Inc. published this content on 29 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 March 2022 16:43:04 UTC.